Biogaia Financial Statements From 2010 to 2025
| BIOGY Stock | USD 11.00 0.65 6.28% |
Check Biogaia AB financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biogaia AB's main balance sheet or income statement drivers, such as , as well as many indicators such as . Biogaia financial statements analysis is a perfect complement when working with Biogaia AB Valuation or Volatility modules.
Biogaia |
Biogaia AB ADR Company Current Valuation Analysis
Biogaia AB's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Biogaia AB Current Valuation | 719.05 M |
Most of Biogaia AB's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biogaia AB ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Biogaia AB ADR has a Current Valuation of 719.05 M. This is 94.99% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The current valuation for all United States stocks is 95.67% higher than that of the company.
Biogaia AB ADR Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biogaia AB's current stock value. Our valuation model uses many indicators to compare Biogaia AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biogaia AB competition to find correlations between indicators driving Biogaia AB's intrinsic value. More Info.Biogaia AB ADR is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers reporting about 0.54 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Biogaia AB ADR is roughly 1.86 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Biogaia AB by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Biogaia AB's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Biogaia AB Financial Statements
Biogaia AB investors use historical fundamental indicators, such as Biogaia AB's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Biogaia AB. Please read more on our technical analysis and fundamental analysis pages.
BioGaia AB develops, markets, and sells probiotic products with documented health benefits worldwide. BioGaia AB was founded in 1990 and is headquartered in Stockholm, Sweden. Biogaia Ag is traded on OTC Exchange in the United States.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Biogaia Pink Sheet Analysis
When running Biogaia AB's price analysis, check to measure Biogaia AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogaia AB is operating at the current time. Most of Biogaia AB's value examination focuses on studying past and present price action to predict the probability of Biogaia AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogaia AB's price. Additionally, you may evaluate how the addition of Biogaia AB to your portfolios can decrease your overall portfolio volatility.